When a child bruises easily or bleeds far longer than expected after a minor cut, it can be alarming for any parent. For families living with haemophilia, this is an everyday reality – one shaped not by carelessness, but by a genetic condition that disrupts the body’s ability to stop bleeding. Haemophilia is widely recognised as the most common severe hereditary bleeding disorder, and yet it remains widely misunderstood. Building a clear, foundational understanding of what haemophilia is, how it works, and how it affects people’s lives is the essential first step toward better care, support, and inclusion.
Table of Contents
- What is haemophilia?
- The major types of haemophilia
- Haemophilia A (classic haemophilia)
- Haemophilia B (Christmas disease)
- Haemophilia C and other rare forms
- How haemophilia is inherited
- Severity levels: mild, moderate, and severe
- Global prevalence: who is affected?
- The impact of haemophilia on daily life
- The economic dimension
- Why understanding haemophilia matters
What is haemophilia?
Haemophilia is a bleeding disorder that slows the blood clotting process. Normally, when a blood vessel is injured, the body responds by activating a chain reaction known as the coagulation cascade – a sequence involving specialised proteins called clotting factors that work together to form a clot and stop bleeding. In a person with haemophilia, one of these clotting factors is either missing or present in dangerously low amounts, so this chain reaction cannot complete properly. The result is prolonged, often uncontrolled bleeding – both externally after injury, and internally within joints and muscles.
What makes haemophilia particularly significant as a disability is its chronic, lifelong nature. It is a lifelong genetic disorder associated with substantial clinical burden, driven by joint bleeding, joint damage, and pain – all of which carry a serious negative impact on daily functioning and overall quality of life.
The major types of haemophilia
Haemophilia is not a single condition – it comes in several forms, each defined by which clotting factor is deficient. Understanding these types is key to understanding the disorder’s scope.
Haemophilia A (classic haemophilia)
Haemophilia A is the most common and well-known form. It is caused by variants in the F8 gene, leading to a deficiency of coagulation Factor VIII (FVIII). It occurs in roughly 1 in every 5,000 males and accounts for approximately 80% of all haemophilia cases. More than half of those diagnosed with haemophilia A have the severe form of the condition, meaning their Factor VIII levels are extremely low.
Haemophilia B (Christmas disease)
Haemophilia B, also called Christmas disease, results from a deficiency of Factor IX (FIX). It is caused by variants in the F9 gene and occurs in approximately 1 in 20,000 newborn males worldwide. Although less common than haemophilia A, its signs, symptoms, and implications for daily life are very similar. Haemophilia A is four times as common as haemophilia B, but both are serious, lifelong conditions.
Haemophilia C and other rare forms
Beyond the two major types, haemophilia C involves a deficiency of Factor XI and follows a different inheritance pattern. Unlike haemophilia A and B, haemophilia C is an autosomal disorder – meaning it is not linked to the X chromosome – and affects both males and females. There is also acquired haemophilia, a non-inherited form where the body develops antibodies that attack its own clotting factors. This rare condition is typically characterised by abnormal bleeding into the skin, muscles, or soft tissues, usually beginning in adulthood.
How haemophilia is inherited
Haemophilia A and B are both X-linked recessive disorders – inherited through the X chromosome. This pattern of inheritance explains why haemophilia is far more common in males than in females. Males carry only one X chromosome (paired with a Y). If that single X chromosome carries the haemophilia gene, the male will have the condition – there is no second X chromosome to compensate.
Females, by contrast, carry two X chromosomes. A female who inherits the haemophilia gene on one X chromosome typically has a healthy allele on her other X chromosome, which provides some protection. This female is called a carrier. She can pass the condition to her children without necessarily having significant bleeding symptoms herself – though some carriers do experience milder forms of bleeding.
When a mother is a carrier, each son has a 1 in 2 (50%) chance of inheriting the haemophilia gene and having the disorder, and each daughter has a 1 in 2 (50%) chance of being a carrier. Importantly, fathers with haemophilia cannot pass the condition directly to their sons – but all of their daughters will become carriers.
It is also worth noting that not all cases are inherited. Around one-third of haemophilia A cases arise with no previous family history – the result of a spontaneous new genetic mutation.
Severity levels: mild, moderate, and severe
Haemophilia is not experienced the same way by everyone with the condition. Healthcare providers classify haemophilia as mild, moderate, or severe based on the amount of clotting factor present in the blood.
In severe haemophilia, clotting factor levels are so depleted that bleeding can occur spontaneously – without any injury at all. In these cases, continuous bleeding that is difficult to control can result in serious complications involving the joints, muscles, brain, or other internal organs. In moderate haemophilia, bleeding is typically triggered by injury or surgery. In the mild form, the condition may go undetected for years – only becoming apparent during a surgical procedure or major trauma.
Global prevalence: who is affected?
Haemophilia affects people of all races and ethnic backgrounds without distinction. Worldwide, more than 200,000 people are estimated to live with some form of haemophilia, though newer data suggest the condition is significantly underdiagnosed – with the actual global population potentially exceeding 1.1 million.
The gap between diagnosed and actual cases is particularly wide in lower-income countries, where diagnostic infrastructure and specialist care are often limited. More than 400,000 males worldwide are estimated to have haemophilia A alone, many of whom remain undiagnosed in the developing world.
The impact of haemophilia on daily life
Haemophilia is more than a medical diagnosis – it is a condition that shapes how a person moves through the world. Long-term spontaneous bleeding into joints and soft tissues can seriously affect the quality of life of patients. Joint bleeds – particularly in the knees, elbows, and ankles – are among the most common and damaging complications. Repeated bleeding into the same joint can lead to a condition called haemophilic arthropathy, a form of chronic joint disease causing pain, swelling, and reduced mobility.
The psychological burden is equally significant. Daily challenges faced by people with haemophilia and their caregivers can have a considerable negative impact on well-being and psychosocial functional status. Anxiety about unexpected bleeds, limitations on physical activity, and the demands of ongoing treatment routines can all take a toll on mental health. The condition’s impact on work and personal relationships is also a serious concern for patients – with many experiencing difficulties in sustaining employment or participating fully in social life.
The economic dimension
The financial cost of managing haemophilia is substantial. In the United States, the average annual cost of managing haemophilia B alone exceeds $200,000 per patient, rising beyond $630,000 for those with the severe form. Across Europe, similar figures have been reported, with clotting factor medications accounting for nearly 98% of direct treatment costs. For families in low- and middle-income countries, access to these treatments is often severely restricted – creating significant health inequities on a global scale.
Why understanding haemophilia matters
Haemophilia is often called “the disease of kings” – a reference to its documented presence in the royal families of 19th-century Europe, particularly through Queen Victoria’s descendants. But it is emphatically not a condition of the past or of the privileged. It is a present-day reality for millions of individuals and families across every corner of the globe.
Understanding haemophilia – what it is, how it is passed from one generation to the next, the different forms it takes, and the way it affects a person’s entire life – is the foundation for meaningful support. For educators, caregivers, healthcare workers, and communities, this knowledge directly informs how well an individual with haemophilia is included, accommodated, and empowered. Good quality medical care from professionals who understand the disorder, combined with community support and education, can help prevent serious complications and significantly improve quality of life.
The World Federation of Hemophilia continues to lead international efforts to improve access to care, treatment standards, and awareness – underscoring that haemophilia is not merely a personal health condition but a public health priority deserving systemic attention.
What do you think? If you were supporting a student or family member with severe haemophilia, what aspects of their daily life do you think would need the most attention – physical, emotional, or social? And how well do you think current school or workplace environments are equipped to accommodate someone living with a chronic bleeding disorder like haemophilia?
References
- https://www.ncbi.nlm.nih.gov/books/NBK551607/
- https://medlineplus.gov/genetics/condition/hemophilia/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8048516/
- https://www.ncbi.nlm.nih.gov/books/NBK470265/
- https://www.bleeding.org/bleeding-disorders-a-z/types/hemophilia-a
- https://en.wikipedia.org/wiki/Haemophilia
- https://pubmed.ncbi.nlm.nih.gov/16684001/
- https://www.cdc.gov/hemophilia/testing/how-hemophilia-is-inherited.html
- https://my.clevelandclinic.org/health/diseases/14083-hemophilia
- https://www.pfizer.com/disease-and-conditions/hemophilia
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8808448/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8091596/
- https://www.cdc.gov/hemophilia/living-with/index.html
- https://www.wfh.org
Leave a Reply